0

2020 - 2005

CHANDRA RAYIDI
 1

CHAPTER 1 : INFECTIOUS DISEASES

10 Marks

1.Describe the etiology , clinical features & complications of AIDS . How will
you treat AIDS ? (Jan 20)
2+2+2+4=10

2.Write clinical features , investigations & treatment of Enteric Fever (Jan 19)
3+3+4=10

3.Write the clinical features , complications & management of Falciparum

Malaria (Aug 14)
3+3+4=10

4.Describe clinical features , laboratory investigations & management of

Falciparum Malaria (Feb 13)
3+3+4=10

5. Write clinical features , investigations & management of Enteric Fever

(Feb 12)
3+3+4=10

6.Write pathophysiology , diagnosis & treatment of Cholera (Aug 11)

4+2+4=10

7.Write manifestations , diagnosis & treatment of Cerebral Malaria (Aug 10)

4+3+3=10

8.What is HAART (Highly Active Anti Retroviral Therapy) ? Mention the classes
of drugs & their use in clinical practice (March 09)
3+3+4=10

9.Discuss the lifecycle of Plasmodium falciparum . Discuss the diagnosis &

treatment of Cerebral Malaria (April 07) 4+3+3=10
 2

4 Marks

1.Complications & treatment of Cerebral Malaria (Jan 20)

2.Amoebiasis (Jan 20)
3.Chickenpox (Jan 20)
4.Genital Herpes simplex (July 19)
5.Chemoprophylaxis for Falciparum Malaria (Jan 19)
6.Complications of Typhoid Fever (July 18)
7.Treatment of Kala-Azar (Visceral Leishmaniasis) (July 18)
8.Clinical features & treatment of Granuloma inguinale (Jan 18)
9.Clinical features & management of Dengue Hemorrhagic Fever (July 17)
10.Giardiasis (July 17)
11.Clinical features & complications of Mumps (Jan 17)
12.Clinical features & management of Leptospirosis (Jan 17)
13.HIV Counselling (July 16)
14.Treatment of Amoebiasis (Jan 16)
15.HAART (Highly Active Antiretroviral Therapy) (Jan 16)
16.Clinical features & management of Dengue Hemorrhagic Fever (Aug 15)
17.Pneumocystis jirovecii (Aug 15)
18.Clinical features & complications of Leptospirosis (Aug 15)
19.Oppurtunistic infections of HIV (Jan 15)
20.Lepra reaction (Jan 15)
21.Congenital syphilis (Jan 15)
22.Cysticercosis (Jan 15)
23.Complications of Typhoid Fever (Aug 14)
24.Treatment of Syphilis (Aug 14)
25.Causative organisms , epidemiology & clinical features of Shigellosis (Jan 14)
26.Clinical features & complications of Mumps (Jan 14)
27.Complications of Dengue Fever (Aug 13)
28.Giardiasis (Aug 13)
29.Diphtheria (Feb 13)
30.Nosocomial infection (Feb 13)
31.Chronic Amoebiasis (Aug 12)
32.Pertussis (Aug 12)
33.Leptospirosis (Aug 12)
34.Oppurtunistic infections of HIV (Aug 12)
35.Food Poisoning (Aug 12)
36.Anthrax (Feb 12)
 3

37.Anti retroviral drugs (Feb 12)

38.Treatment of Enteric Fever (Aug 11)
39.Type-II Lepra reaction (Aug 11)
40.Pathophysiology of Cholera (Feb 11)
41.Systmeic manifestations of AIDS (Aug 10)
42.Differences between Amoebic dysentery & Bacillary dysentery (Aug 10)
43.Food poisoning (Sept 09)
44.HAART (Sept 09)
45.Botulism (Sept 09)
46.Treatment of Cholera (March 09)
47.Yellow fever vaccine (March 09)
48.Diference between Lepromatous & Non Lepromatous Leprosy (Sept 08)
49.Complications of Falciparum Malaria (March 08)
50.Treatment of Multibacillary Leprosy (March 08)
51.Drug therapy of Amoebic Liver Abscess (Sept 07)
52.Rifampicin (Sept 07)
53.Drug therapy of Kala-Azar (April 07)
54.Imidazoles (April 07)

2 Marks

1.Write about Pulmonary eosinophilia (Jan 20)

2.Hemorrhagic viral fevers (Jan 20)
3.Coomb’s test (July 19)
4.Chloroquine (July 19)
4.Clinical features of Tetanus (July 19)
5.HAART (Highly Active Anti Retroviral Treatment) (Jan 19)
6.Weil-Felix Test (Jan 19)
7.Weil’s disease (July 18)
8.Brucellosis (July 18)
9.Treatment of Filariasis (July 18)
10.Chemoprophylaxis of Malaria (July 17)
11.Opportunistic infections in HIV (July 17)
12.Lymphogranuloma venereum (July 17)
13.Botulism (Jan 17)
14.Complications of Leptospirosis (July 16)
15.Treatment of Filariasis (July 16)
16.Nosocomial Infections (July 16)
 4

17.Scrub Typhus (July 16)

18.Prion diseases (Jan 16)
19.Tertiary Syphilis (Jan 16)
20.Giardiasis (Aug 15)
21.Ascariasis (Aug 15)
22.Treatment of Vivax Malaria (Jan 15)
23.Clinical features of Leptospirosis (Aug 14)
24.Mention the drugs & side effects of Protease Inhibitors (PIs) (Jan 14)
25.Treatment of Brucellosis (Aug 13)
26.Extra intestinal Amoebiasis (Feb 13)
27.Treatment of Cholera (Feb 13)
28.Gastro intestinal complication of AIDS (Feb 13)
29.Larva migrans (Aug 12)
30.Resistant Malaria (Feb 12)
31.Lepra reaction (Feb 12)
32.Treatment of Gonorrhoea (Aug 11)
33.Tetany (Aug 11)
34.Symptoms of Dengue Fever (Aug 11)
35.Diagnosis of Leptospirosis (Feb 11)
36.Tetanus toxoid & its significance (Feb 11)
37.Typhoid vaccine (Aug 10)
38.Mumps (Aug 10)
39.Dapsone (Sept 09)
40.Giardiasis (March 09)
41.Tetany (Sept 08)
42.Reactions in Leprosy (Sept 08)
43.Nucleoside reverse transcriptase inhibitors (Sept 08)
44.Etiology & clinical presentation in Leptospirosis (March 08)
45.Tropical Pulmonary Eosinophilia (March 08)
46.Brugia malayii (Sept 07)
47.Quinine (Sept 07)
48.Itching around anus (Sept 07)
49.Fluconazole (Sept 07)
50.Bubo (Sept 07)
51.Cutaneous lesion in Anthrax (April 07)
52.Chloroquine (April 07)
53.Yellow fever vaccine (April 07)
 5

CHAPTER 2 : DISEASES OF RESPIRATORY SYSTEM

10 Marks

1.Write the causes , clinical features & treatment of Acute Lobar Pneumonia
(Jan 19)
3+3+4=10

2.Write causes , clinical features & management of Pneumothorax (Jan 18)

10

3.Write etiology , pathogenesis , clinical features of Bronchial Asthma &

management of Acute Severe Asthma (Jan 17)
2+2+3+3=10

4.Enumerate the causes of Suppurative Lung disease . Discuss the clinical

features & management of Empyema Thoracis (July 16)
3+3+4=10

5.Write the etiology , pathogenesis & clinical features of Bronchial Asthma .

Add a note on management of Acute Severe Asthma (Aug 15)
2+2+3+3=10

6.Mention etiology , clinical features & management of Lung Abscess (Jan 15)
3+3+4=10

7.Write the causes , clinical features & management of Bronchiectasis (Aug 14)
3+3+4=10

8.Write the clinical features , complications & management of Bronchial

Asthma (Jan 14)
3+2+5=10

9.Write diagnosis & management of Bronchial Asthma (Aug 11)

5+5=10
 6

10.Discuss the clinical features , laboratory investigations & management of

Pleural Effusion (Sept 09)
3+3+4=10

11.Write the clinical signs of fibrosis (pleural & parenchymal) & cavity in the
lung . Write in detail the drug treatment of Pulmonary TB . Mention the
adverse reactions of major drugs (April 07)
2+2+4+2=10

4 Marks

1.Bronchial asthma (Jan 20)

2.Hemoptysis (July 19)
3.Investigations & management of Pleural Effusion (Jan 16)
4.Cystic Fibrosis (Aug 13)
5.Status Asthmaticus (Feb 13)
6.Bronchiectasis (Feb 13)
7.Pneumothorax (Aug 12)
8.DOTS Regimen (Aug 11)
9.Community acquired Pneumonia (Feb 11)
10.Pleural Effusion (Feb 11)
11.Role of steroids in management of Asthma (Feb 11)
12.MDR TB (Aug 10)
13.Pulmonary Function Tests (Sept 09)
14.Lung lesions in retro viral infection (March 09)
15.Pulmonary function test in Bronchial Asthma (March 09)
16.Management of Acute Severe Asthma (March 08)
17.Histology of Tuberculoma (Sept 07)

2 Marks

1.Name 2 Pulmonary Function Tests (Jan 20)

2.Name 2 Occupational Lung Diseases (Jan 20)
3.FEV 1 (July 19)
4.Pleural Fluid Analysis in Synpneumonic Effusion (Jan 19)
5.Hypertrophic Pulmonary Osteopathy (July 18)
6.Pneumoconiosis (July 18)
7.Pleural Fluid Analysis in Malignant Pleural Effusion (July 18)
 7

8.Pleurodesis (Jan 18)

9.Sweat Chloride Test (July 17)
10.Clinical features of Bronchiectasis (July 17)
11.Mention causes of Hemoptysis (July 17)
12.Adult vaccines in COPD (Jan 16)
13.Paraneoplastic manifestations of Lung cancer (Jan 16)
14.Pleural Fluid Analysis in Tubercular Pleural Effusion (Aug 14)
15.Mention the causes of Hemoptysis (Aug 13)
16.Pulmonary Function Tests (Feb 12)
17.Mention types of Pneumothorax (Feb 12)
18.Enumerate different Occupational Lung Diseases (Aug 11)
19.Interstitial Lung Disease (Feb 11)
20.Peak Flow Rate & its significance (Aug 10)
21.RNTCP (Sept 09)
22.Mantoux test (March 09)
23.MDR TB (Sept 08)
24.Etiology of Community acquired Pneumonia (March 08)
25.Vital capacity (Sept 07)
26.Tension Pneumothorax (April 07)
 8

CHAPTER 3 : DISEASES OF CARDIOVASCULAR SYSTEM

10 Marks

1.What are the causes of Hypertension ? Describe in detail about the clinical
signs & symptoms , complications & management of Hypertension (Jan 20)
3+2+2+3=10

2.Describe the etiology , clinical features & management of Congestive Cardiac

Failure (July 19)
10

3.Write clinical features , diagnosis & treatment of Infective Endocarditis

(July 18)
3+3+4=10

4.Discuss the causes ,signs & symptoms , treatment & complications of Acute
Myocardial Infarction (Jan 18)
10

5.Write etiology , clinical features & management of Congestive Cardiac Failure

(July 17)
3+3+4=10

6.Discuss the diagnosis & treatment of Infective Endocarditis . Add a note on

prevention of Infective Endocarditis (Jan 17)
5+3+2=10

7.Clinical features & management of Acute Rheumatic Fever . Mention briefly

Rheumatic Fever prophylaxis (July 16)
4+3+3=10

8.Write various causes , organ manifestations & treatment of Hypertension

(Aug 15)
3+3+4=10
 9

9.Write the risk factors , clinical features & management of Angina Pectoris
(Jan 15)
3+3+4=10

10.Write the etiology , clinical features , complications & management of

Infective Endocarditis (Jan 14)
3+3+2+2=10

11.Write the clinical features , complications & management of Acute

Myocardial Infarction (Aug 13)
3+3+4=10

12.Discuss the etiology , clinical features & management of Congestive Cardiac

Failure (Feb 13)
3+3+4=10

13.Discuss the clinical features , laboratory investigations & management of

Acute Myocardial Infarction (Aug 12)
3+3+4=10

14.Write syndromes , signs & management of Mitral Stenosis (Feb 11)

10

15.Enumerate various causes , end organ manifestations & treatment of

Hypertension (Aug 10)
3+3+4=10

16.Discuss the diagnosis & prophylaxis of Infective Endocarditis (Sept 09)

5+5=10

17.Draw a diagram of Conducting System of Heart . Write the various Atrio-

Ventricular (AV) blocks . Draw illustrative Electro cardiograms (March 09)
3+3+4=10

18.Discuss the etiology , clinical features & management of Congestive Heart

Failure (Sept 08)
3+3+4=10
 10

19.Describe diagnostic criteria , clinical features , laboratory investigations &

management of Acute Rheumatic Fever (March 08)
2+2+2+4=10

20.Classify Cardiomyopathy . What are the clinical features of each type ?

Outline the treatment (April 07)
2+2+2+2+2=10

4 Marks

1.P-R Interval (July 19)

2.Atrial Fibrillation (Jan 19)
3.Treatment of Digitalis toxicity (Jan 19)
4.Pre-Excitation syndromes (July 18)
5.Fallot’s Tetralogy (July 18)
6.Acute Pericarditis (Jan 18)
7.Treatment of Paroxysmal Supraventricular Tachycardia (Jan 18)
8.Atrial Fibrillation treatment (July 17)
9.Cardio Pulmonary Resuscitation (CPR) (July 16)
10.TEE (Trans Esophageal Echocardiography) (July 16)
11.Complications of Acute Myocardial Infarction (Jan 16)
12.Tetralogy of Fallot (Aug 15)
13.Pericarditis (Jan 15)
14.Complete Heart Block (Aug 14)
15.Left Ventricular Failure (Aug 14)
16.Atrial Fibrillation (Jan 14)
17.Arrythmias in Myocardial Infarction (Feb 12)
18.Ventricular Ectopics (Aug 11)
19.DC Cardioversion (Aug 11)
20.Treatment of Mitral Stenosis (Aug 10)
21.Secondary Hypertension (Sept 08)
22.Serum markers in Acute Myocardial Infarction (March 08)
23.Target organ damage in Hypertension (March 08)
24.Medical closure of PDA (Patent Ductus Arteriosus) (April 07)

2 Marks

1.Cardiomyopathy (Jan 20)

 11

2.Name 2 congenital heart diseases (Jan 20)

3.Atrial Fibrillation (Jan 20)
4.Name 4 ‘B’ Blocker drugs (July 19)
5.Treatment of Acute Rheumatic Fever (Jan 19)
6.Signs of Constrictive Pericarditis (Jan 19)
7.Wenckebach’s phenomenon (Jan 18)
8.Risk factors for Atherosclerosis (July 17)
9.Jones criteria for Rheumatic Fever (Jan 17)
10.Management of Acute Pulmonary Edema (July 16)
11.Secondary Hypertension (Jan 16)
12.Causes of Atrial Fibrillation (Jan 15)
13.Syncope (Jan 15)
14.Supraventricular Tachycardia (Aug 14)
15.Treatment of Acute Myocardial Infarction (Aug 14)
16.Clinical features of Marfan’s syndrome (Jan 14)
17.Mention Calcium Channel Blockers with doses (Aug 13)
18.Mention the causes of Secondary Hypertension (Aug 13)
19.Pulsus paradoxus (Feb 13)
20.Collapsing pulse (Aug 12)
21.Beta Blockers (Feb 12)
22.Differences between Atrial Flutter & Atrial Fibrillation (Aug 11)
23.CCF (Congestive Cardiac Failure) (Aug 11)
24.TOF (Tetralogy of Fallot) (Feb 11)
25.Enumerate principles of treatment of Acute MI (Myocardial Infarction)
(Feb 11)
26.Infective Endocarditis prophylaxis (Aug 10)
27.Atrial Flutter (Aug 10)
28.Angiotensin receptor blockade (March 09)
29.Beta Blockers (Sept 08)
30.Digitalis (March 08)
31.Fallots Tetralogy (March 08)
32.Cor pulmonale (March 08)
33.ECG in Ventricular Ectopic beat (April 07)
 12

CHAPTER 4 : DISEASES OF GASTROINTESTINAL SYSTEM

10 Marks

1.Describe the causes , clinical features & management of Acid Peptic disease
(Aug 12)
3+3+4=10

4 Marks

1.Irritable Bowel Syndrome (Jan 17)

2.Causes & complications of Chronic Pancreatitis (Jan 16)
3.Zollinger-Ellison syndrome (Aug 15)
4.Ulcerative colitis (Aug 15)
5.Irritable Bowel Syndrome (Jan 15)
6.Etiology , clinical features & treatment of Zollinger-Ellison syndrome (Jan 14)
7.Reflux oesophagitis (Aug 13)
8.Inflammatory Bowel Disease (Feb 12)
9.Management of Acute Pancreatitis (Aug 10)
10.Irritable Bowel Syndrome (Sept 09)
11.Ulcerative colitis (Sept 08)
12.Gastro oesophageal reflex (Sept 07)

2 Marks

1.Colonoscopy (July 19)

2.Plummer-Vinson syndrome (Jan 19)
3.Whipple’s disease (Jan 19)
4.Treatment of Irritable Bowel Syndrome (IBS) (July 18)
5.Management of H. pylori infection (Jan 18)
6.Complications of Ulcerative colitis (Jan 18)
7.Diagnosis of Gluten-Sensitive Enteropathy (Jan 18)
8.Treatment of Peptic Ulcer (July 17)
9.Clinical features of Whipple’s disease (July 17)
10.Complications of Acute Pancreatitis (Jan 17)
 13

11.Clinical features of Plummer-Vinson syndrome (Jan 17)

12.Pancreas divisum (July 16)
13.Colonoscopy (July 16)
14.Complications of Peptic Ulcer disease (Jan 16)
15.Management of Irritable Bowel Syndrome (Aug 14)
16.Mention 2 contraindications & 2 complications of Upper Gastrointestinal
Endoscopy (Jan 14)
17.Mention 4 important clinical features of Whipple’s disease (Jan 14)
18.Mention 4 Proton Pump Inhibitors with dosage (Jan 14)
19.Carcino Embryonic Antigen (CEA) (Jan 14)
20.Mention the complications of Pancreatitis (Aug 13)
21.Mention the classes of drugs used in the treatment of Peptic Ulcer (Aug 13)
22. Etiology of Tropical Sprue (Feb 13)
23.Mention Proton Pump Inhibitors with dosage (Aug 12)
24.Treatment of Peptic Ulcer (Feb 11)
25.Helicobacter pylori (Sept 09)
26.Proton Pump Inhibitors (Sept 08)
27.Prokinetic drugs (March 08)
28.Causes of Malena (Sept 07)
29.Oesophageal stricture (April 07)
30.Drug treatment of Oesophageal Varices (April 07)
 14

CHAPTER 5 : DISEASES OF NERVOUS SYSTEM

10 Marks

1.Classify Motor Neuron Diseases . Discuss the clinical features , investigations

& management of Amyotrophic Lateral Sclerosis (July 19)
10

2.Write the etiology , clinical features , investigations & treatment of Acute

Pyogenic Meningitis (Jan 19)
2+2+2+4=10

3.Enumerate involuntary movements . Discuss clinical features & treatment of

Parkinson’s disease (July 18)
2+4+4=10

4.Discuss the clinical features , laboratory investigations of Pyogenic Meningitis

(Jan 18)
10

5.Write the clinical features , complications & management of Tuberculous

Meningitis (July 17)
3+3+4=10

6.Discuss the clinical features , laboratory investigations & management of

Subarachnoid Hemorrhage (Jan 17)
3+3+4=10

7. Enumerate involuntary movements . Discuss clinical features & treatment of

Parkinson’s disease (July 16)
2+4+4=10

8.Write clinical features & management of Migraine (Aug 15)

5+5=10
 15

9.Classify Motor Neuron Diseases . Discuss the clinical features , investigations

& management of Amyotrophic Lateral Sclerosis (Jan 15)
2+3+2+3=10

10.Write the causative agents , clinical features , investigations & management

of Pyogenic Meningitis (Aug 14)
2+2+2+4=10

11.Write the pathology , clinical features & management of Parkinson’s disease

(Jan 14)
2+4+4=10

12.Mention the clinical features , complication & treatment of Tuberculous

Meningitis (Aug 13)
3+3+4=10

13.Describe the causes , clinical features & management of Parkinson’s disease

(Aug 12)
3+3+4=10

14.Describe the clinical features , investigations & management of Pyogenic

Meningitis (Feb 12)
3+3+4=10

15.Mention the differences in findings between Upper Motor Neuron (UMN) &
Lower Motor Neuron (LMN) lesion . Write the principles of treatment of Stroke
(Aug 11)
5+5=10

16.Enumerate causes of Meningitis . Write diagnosis & treatment of Pyogenic

Meningitis (Feb 11)
10

17.Discuss the clinical features , laboratory investigations & management of

Subarachnoid hemorrhage (Sept 09)
3+3+4=10

18.Describe the clinical features & management of Parkinsonism (Sept 08)

5+5=10
 16

19.Discuss the clinical features , laboratory investigations & management of

Pyogenic Meningitis (March 08)
3+3+4=10

20.What are the risk factors in developing Intracerebral hemorrhage ? Describe

the clinical features , diagnosis & treatment of Subarachnoid hemorrhage (Sept
07)
2+3+2+3=10

21.How do you clinically localize the anatomical level of lesion in spinal cord
diseases ? What are the clinical features of intermedullary lesion at C4 C5 C6
(cervical level 4,5,6) ? (Sept 07)
5+5=10

4 Marks

1.Parkinsonism (Jan 20)

2.Encephalitis (Jan 20)
3.CSF in Pyogenic Meningitis (July 19)
4.Tabes dorsalis (July 18)
5.Treatment of Neurocysticercosis (Jan 18)
6.Complications of Stroke (July 17)
7.Motor Neuron Disease (MND) (Jan 17)
8.Diagnosis of Myasthenia Gravis (Jan 16)
9.Jacksonian Epilepsy (Aug 13)
10.Myasthenia Gravis – clinical features & investigations (Aug 13)
11.Motor Neuron Disease (MND) (Feb 13)
12.Progressive Bulbar Palsy (Feb 13)
13.Viral Encephalitis (Aug 12)
14.Migraine (Feb 12)
15.Treatment of Parkinsonism (Aug 11)
16.Treatment of Trigeminal Neuralgia (Feb 11)
17.Chorea (Feb 11)
18.Duchenne Muscular Dystrophy (Feb 11)
19.Pseudotumour cerebri (Aug 10)
20.Lumbar puncture (Sept 09)
21.Management of Migraine (Sept 09)
22.CSF in Tuberculous Meningitis (March 09)
23.Post herpetic Neuralgia (March 09)
 17

24.Sensory deficit in Syringomyelia (March 09)

25.Amyotrophic Lateral Sclerosis (Sept 08)
26.CNS Manifestations of Tuberculosis (Sept 08)
27.Duchenne Muscular Dystrophy (March 08)
28.Management of Status Epilepticus (March 08)
29.Spino Cerebellar Degeneration (April 07)
30.Complex Partial Seizure (April 07)

2 Marks

1.Myasthenia Gravis (Jan 20)

2.Coma (Jan 20)
3.Name 4 signs of Meningeal irritation (July 19)
4.Diagnosis of Brain death (Jan 19)
5.Treatment of Status Epilepticus (July 18)
6.Treatment of Myasthenia Gravis (July 18)
7.Causes of Dementia in elderly (July 17)
8.Syndenham’s chorea (July 17)
9.Complex Partial Seizures (Jan 17)
10.Transient Ischemic Attack (TIA) (Jan 17)
11.Risk factors for Ischemic Stroke (July 16)
12.Diagnosis of Brain death (Jan 16)
13.Hemifacial Spasm (Jan 16)
14.Treatment of Trigeminal Neuralgia (Aug 15)
15.Asterixis (Aug 15)
16.Causes of Dementia (Aug 15)
17.Subarachnoid hemorrhage (Jan 15)
18.Guillian Barre Syndrome (Jan 15)
19.Todd’s Paralysis (Aug 14)
20.Different causes of Parkinsonism (Aug 14)
21.Name 4 recent drugs used in Migraine (Jan 14)
22.Syndenham’s chorea (Aug 13)
23.Transient Ischemic Attack (Aug 13)
24.Raised Intracranial Tension (ICT) (Feb 13)
25.Bell’s Palsy (Aug 12)
26.Lower Motor Neuron lesion (Aug 12)
27.Causes of Dementia (Feb 12)
28.Trigeminal Neuralgia (Feb 12)
 18

29.Classification of Epilepsy (Aug 11)

30.Mention the types of Motor Neuron Disease (MND) (Aug 11)
31.Treatment of Migraine (Feb 11)
32.Treatment of Neurocysticercosis (Feb 11)
33.Bell’s Palsy (Aug 10)
34.Bell’s Palsy (Sept 09)
35.Amyotrophic Lateral Sclerosis (Sept 09)
36.Etiology of Dementia (Sept 09)
37.Mini Mental Examination (March 09)
38.Operative treatment of Trigeminal Neuralgia (March 09)
39.Computerised Tomography in Stroke (Sept 08)
40.Cluster headache (Sept 08)
41.Etiology of Stroke in young (Sept 08)
42.Newer Anti-Epileptics (Sept 08)
43.Trigeminal Neuralgia (March 08)
44.Xanthochromia in CSF Fluid (Sept 07)
 19

CHAPTER 6 : DISEASES OF BLOOD

10 Marks

1.Describe the etiopathogenesis , clinical features , diagnosis & treatment of

Megaloblastic Anemia (July 19)
10

2.Write the clinical features , cytogenic & chromosomal abnormalities &

management of Chronic Myeloid Leukemia (July 18)
3+3+4=10

3.Discuss causes , clinical features & management of Megaloblastic Anemia

(Jan 18)
10

4.Describe the clinical features , laboratory investigations & management of

Megaloblastic Anemia (Feb 13)
3+3+4=10

5.Write causes , diagnosis & treatment of Iron Deficiency Anemia (Feb 11)
4+3+3=10

6.Write the clinical features , diagnosis & management of Hodgkin’s

Lymphoma (Aug 10)
4+3+3=10

7.Describe clinical features , laboratory investigations & management of

Chronic Myeloid Leukemia (Sept 08)
3+3+4=10

8.Discuss the clinical features , laboratory investigations & management of

Megaloblastic Anemia (March 08)
3+3+4=10
 20

9.What are the indications of Bone marrow transplantation ? Write the

technique . What are the immediate & late complications ? (Sept 07)
2+3+2+3=10

10.Outline the Blood Coagulation Cascade . Write the etiology , clinical features
& treatment of Hemophiles (April 07)
3+2+3+2=10

4 Marks

1.Chronic Myeloid Leukemia (Jan 20)

2.Causes of Polycythemia (July 18)
3.Hemophilia (July 17)
4.Complications of Blood Transfusion (Jan 17)
5.Usefulness of Reticulocyte count (July 16)
6.Treatment of Chronic Myeloid Leukemia (July 16)
7.Causes of Polycythemia (Jan 16)
8.Sickle cell Anemia (Aug 15)
9.Polycythemia rubra vera (Aug 15)
10.Clinical features & investigations of Megaloblastic Anemia (Jan 14)
11.Glucose-6-Phosphate dehydrogenase deficiency (Aug 13)
12.Acute Leukemia (Aug 12)
13.Polycythemia (Aug 12)
14.Hemolytic Anemia (Feb 12)
15.Treatment of Acute Leukemia (Feb 12)
16.Treatment of Iron Deficiency Anemia (Aug 11)
17.Peripheral smear in Chronic Myeloid Leukemia (Feb 11)
18.Idiopathic Thrombocytopenic Purpura (Aug 10)
19.Laboratory features of Acute Intravascular Hemolysis (March 09)
20.Graft versus Host reaction (March 09)
21.Laboratory tests for RBC Hemolysis (Sept 07)

2 Marks

1.Clinical features of B12 deficiency (Jan 20)

2.Warfarin (July 19)
3.Name 4 Anti Platelet drugs (July 19)
4.Sickle cell Anemia (Jan 19)
 21

5.Serum Ferritin (Jan 18)

6.Indications for Bone Marrow Transplantation (July 17)
7.Indications of Bone marrow aspiration study (July 16)
8.Traetment of ITP (Idiopathic Thrombocytopenic Purpura) (Jan 16)
9.Multiple myeloma (Aug 15)
10.Thalessemia minor (Jan 15)
11.Waldenstrom’s Macroglobulinemia (Aug 14)
12.Drug induced Purpura (Aug 12)
13.Multiple myeloma (Aug 11)
14.Thrombocytopenia (Feb 11)
15.Microcytic Hypochromic Anemia (Sept 09)
16.Multiple myeloma (Sept 08)
17.Disseminated Intravascular Coagulation (March 08)
18.Absorption of Cyanocobalamine (Sept 07)
19.Hypersplenism (Sept 07)
 22

CHAPTER 7 : DISEASES OF LIVER & BILIARY SYSTEM

10 Marks

1.Mention the etiology , clinical features & management of Acute Viral

Hepatitis (Aug 13)
3+3+4=10

2.Describe clinical features , laboratory investigations & management of

Cirrhosis of Liver (Feb 13)
3+3+4=10

4 Marks

1.Mention 4 Liver Function Tests (July 19)

2.Liver Function Tests (July 18)
3.Treatment of Acute Fulminant Hepatitis (Jan 18)
4.Extra hepatic complications of Hepatitis C (July 17)
5.Gynecomastia & its causes (July 16)
6.Hepatitis C (Aug 15)
7.Liver Function Tests (Aug 14)
8.Etiology , clinical features & differential diagnosis of Hepatic Encephalopathy
(Jan 14)
9.Chronic Active Hepatitis (Feb 12)
10.Hepatitis B vaccines (Sept 09)
11.Management of Hepatic Encephalopathy (Sept 08)
12.Liver Function Tests (March 08)

2 Marks

1.Write about Alcoholic Hepatitis (Jan 20)

2.Viral markers of Hepatitis B (July 19)
3.Signs of Hepatocellular insufficiency (Jan 19)
4.Viral markers in Chronic Hepatitis (July 18)
5.Mention the complications of Portal Hypertension (Jan 18)
 23

6.Prevention of Hepatitis B (Jan 17)

7.Management of Cholelithiasis (Jan 17)
8.Indications for Liver biopsy (July 16)
9.Clinical features of Portal Hypertension (July 16)
10.Complications of Hepatitis B (Jan 16)
11.Complications of Cirrhosis (Jan 15)
12.Causes of Chronic Hepatitis (Jan 15)
13.Signs of Hepatocellular Failure (Aug 14)
14.Mention 4 complications of Portal Hypertension (Jan 14)
15.Causes & treatment of Spontaneous Bacterial Peritonitis (SBP) (Jan 14)
16.Indications for Liver transplantation (Aug 12)
17.Causes of Portal Hypertension (Feb 12)
18.Peritoneal fluid analysis in Cirrhosis of Liver (Aug 11)
19.Signs of Hepatic Encephalopathy (Aug 11)
20.Liver transplantation (Feb 11)
21.Pathopysiology of Ascites (Aug 10)
22.Liver function tests in Acute Hepatitis (Aug 10)
23.Pathogenesis of Ascites (Sept 09)
24.Alkaline Phosphatase (March 09)
25.Management of Acute Variceal bleeding (March 08)
26.Serum Alkaline Phosphatase (Sept 07)
27.Urobilinogen (Sept 07)
 24

CHAPTER 8 : DISEASES OF KIDNEY & URINARY TRACT

10 Marks

1.Write the etiology , clinical features , complications & management of Acute

Glomerulonephritis (July 17)
1+3+3+3=10

2.Write causes , clinical features & management of Chronic Renal Failure

(Jan 16)
3+3+4=10

3.Write etiology , clinical features & management of Nephrotic Syndrome

(Aug 13)
3+3+4=10

4.Describe the causes , clinical features & management of Chronic Renal

Failure (Aug 12)
3+3+4=10

5.Discuss the etiology , clinical features , laboratory investigations &

management of Nephrotic Syndrome (Feb 12)
3+2+2+3=10

6.Write the symptoms , diagnosis & treatment of Nephrotic Syndrome (Feb 11)
10

7.Discuss the etiology , clinical features , laboratory investigations &

management of Acute Renal Failure (Sept 09)
2+2+2+4=10

8.Draw a diagram of Nephron . List the diuretics used in clinical sites & their
anatomical sites of action (March 09)
3+3+4=10
 25

9.Discuss the clinical features , laboratory investigations & manifestations of

Nephrotic Syndrome (Sept 08)
3+3+4=10

4 Marks

1.Nephrotic Syndrome (Jan 20)

2.Indications for Hemodialysis (July 19)
3.Treatment of Acute Proliferative Glomerulonephritis (Jan 19)
4.Renal Function Tests (RFT) (Jan 19)
5.Essentials for diagnosis of Nephrotic Syndrome (July 18)
6.Treatment of Acute Renal Failure (July 18)
7.Treatment of Acute Pyelonephritis (Jan 18)
8.Complications of Nephrotic Syndrome (Jan 17)
9.Lupus nephritis (July 16)
10.IgA Nephropathy (Aug 15)
11.Renovascular Hypertension (Jan 15)
12.Urinary Tract Infection in males (Jan 15)
13.Hemodialysis (Jan 15)
14.Treatment of Acute Post Streptococcal Glomerulonephritis (Aug 14)
15.Etiopathogenesis , clinical features & investigations of Polycystic Kidney
Disease (Jan 14)
16.Management of Pyelonephritis (Aug 11)
17.Causes of Acute Renal Failure (Aug 11)
18.Urinary Tract Infection in males (Aug 10)
19.Forced Alkaline Diuresis (March 09)
20.Indications of Dialysis (March 08)
21.Renal handling of Uric Acid (Sept 07)
22.Microproteinuria (April 07)

2 Marks

1.Write about Acute Renal Failure (Jan 20)

2.Name 4 Nephrotoxic drugs (July 19)
3.Causes of Hematuria (July 19)
4.Causes of Hematuria (Jan 18)
5.Mention the causes of Acute Renal Failure (Jan 17)
6.Microalbuminaria (July 16)
 26

7.Causes of Acute Renal Failure (Aug 15)

8.Significant bacteriuria (Jan 15)
9.Mention indications for Dialysis (Aug 14)
10.Mention the causes of Acute Renal Failure (Jan 14)
11.Mention the recent drugs used in the treatment of Urinary Tract Infection
(Aug 13)
12.Clinical features of Acute Nephritis (Feb 13)
13.Drug induced Nephropathy (Feb 13)
14.Polycystic Kidney (Feb 12)
15.Mention Nephrotoxic drugs (Feb 12)
16.Urine microscopy in Acute Renal Failure (Aug 10)
17.Serum Uric Acid (March 09)
18.Endocrine functions of kidney (Sept 07)
19.Microscopic deposits in urine (April 07)
 27

CHAPTER 9 : ENDOCRINOLOGY & DIABETES MELLITUS

10 Marks

1.Write about the clinical features and management of Diabetic Ketoacidosis

(Jan 20)
4+6=10

2.Write the clinical features & investigations of Hypothyroidism (July 16)

4+6=10

3.Write the etiology , clinical features , investigations & management of

Thyrotoxicosis (Aug 15)
2+3+3+2=10

4.Write the clinical features & management of Diabetic Ketoacidosis (Jan 15)
10

5.Write the clinical features , complications & management of Grave’s disease

(Jan 14)
3+3+4=10

6.Discuss the clinical features , laboratory investigations & management of

Thyrotoxicosis (March 08)
3+3+4=10

4 Marks

1.Addison’s disease(Jan 20)

2.Hypoglycemia (Jan 20)
3.Treatment of Hyperthyroidism (July 19)
4.Diabetes Insipidus (July 19)
5.Oral Hypoglycemic Agents (OHA) (Jan 19)
6.Treatment of Myxedema (July 18)
7.Human Insulins (July 18)
 28

8.Clinical features of Addison’s disease (Jan 18)

9.Clinical features & medical management of Acromegaly (July 17)
10.Management of Diabetic Ketoacidosis (July 17)
11.Cushing syndrome (Jan 17)
12.Treatment of Myxedema coma (Jan 16)
13.Pheochromocytoma (Jan 15)
14.Treatment of Hypercalcemia (Aug 14)
15.Insulin therapy (Aug 14)
16.Clinical features & investigations of Hypothyroidism (Aug 13)
17.Cushing syndrome (Feb 13)
18.Myxedema (Aug 12)
19.Oral Anti Diabetic drugs (Aug 11)
20.Hirsutism (Feb 11)
21.Non ketotic hyperosmolar coma in Diabetes Mellitus (Aug 10)
22.Insulin resistance (Sept 09)
23.Clinical features of Myxedema coma (Sept 08)
24.Newer Insulin Delivery Devices (March 08)
25.Acarbose (April 07)

2 Marks

1.Syndrome X (July 19)

2.Signs of Addison’s disease (Jan 19)
3.Signs of Myxedema (Jan 19)
4.Screening urinary test for Pheochromocytoma (Jan 19)
5. Hung-up Reflex (July 18)
6.Mention acute complications of Diabetic Mellitus (Jan 18)
7.Clinical features of Hypocalcemia (Jan 16)
8.Hyperglycemic Hyperosmolar state (Aug 15)
9.Clinical features of Hypoglycemia (Jan 15)
10.Sheehan’s syndrome (Jan 15)
11.Pretibial myxedema (Aug 14)
12.Addisonian crisis (Aug 14)
13.Clinical features of Acromegaly (Aug 13)
14.Clinical features of Hyperparathyroidism (Feb 13)
15.Neurological complications of Diabetes Mellitus (Aug 12)
16.Clinical features of Addison’s disease (Feb 12)
17.Hypoglycemia (Feb 12)
 29

18.Clinical features of Myxedema (Aug 11)

19.TSH (Thyroid Stimulating Hormone) (Feb 11)
20.Role of genetics in Diabetes Mellitus (Feb 11)
21.Hyperparathyroidism (Sept 09)
22.Thyroid Stimulating Hormone (TSH) (March 09)
23.Clinical features of Diabetic Ketoacidosis (Sept 08)
24.Metformin (March 08)
25.Serum cortisol (April 07)
26.Hirsutism (April 07)
 30

CHAPTER 10 : DISEASES OF IMMUNE SYSTEM , CONNECTIVE

TISSUE & JOINTS

10 Marks

1.Write the etiopathogenesis , clinical features & management of Gout (Jan 20)
3+4+3=10

2.Write the articular & extra articular clinical manifestations of Rheumatoid

Arthritis (July 17)
5+5=10

3.Write the causes , diagnosis & management of Osteoporosis (Jan 17)

3+3+4=10

4.Write the etiopathogenesis , clinical features & management of Gout (Jan 16)
3+4+3=10

5.What are the articular & extra articular clinical manifestations of Rheumatoid
Arthritis ? (Feb 12)
5+5=10

4 Marks

1.Sjogren’s syndrome (July 19)

2.Clinical features & treatment of Acute Gouty Arthritis (Jan 19)
3.Treatment of Rheumatoid Arthritis (Jan 19)
4.Investigations of Osteoporosis (Jan 18)
5.Diagnostic criteria of SLE (Systemic Lupus Erythematosus) (Jan 18)
6.Treatment of Paget’s disease (July 16)
7.SLE Investigations (July 16)
8.Clinical features of Systemic Lupus Erythematosus (SLE) (Jan 16)
9.Pathogenesis & clinical features of Rheumatoid Arthritis (Aug 14)
10.Treatment of SLE (Aug 14)
11.Etiology ,pathogenesis & clinical features of Rheumatoid Arthritis (Aug 13)
 31

12.SLE (Systemic Lupus Erythematosus) (Feb 13)

13.Ankylosing spondylitis (Feb 13)
14.Osteomalacia (Aug 12)
15.Gout (Feb 12)
16.Treatment of Osteoporosis (Aug 11)
17.Treatment of SLE (Feb 11)
18.Diagnostic criteria for Rheumatoid Arthritis (Sept 09)
19.Disease modifying Anti Rheumatoid drugs (Sept 08)
20.Systemic Lupus Erythematosus (March 08)
21.Ainhum (Sept 07)
22.Diagnostic criteria in Rheumatoid Arthritis (April 07)

2 Marks

1.Write about Osteoporosis (Jan 20)

2.Complications of Gout (July 18)
3.Diagnosis of Gout (Jan 17)
4.Complications of Gout (July 16)
5.Osteoporosis (Aug 15)
6.Mention 4 extra articular manifestations of Rheumatoid Arthritis (Aug 15)
7.Complications of Seronegative Arthritis (Jan 15)
8.Anti Nuclear Antibody (Aug 14)
9.Pseudogout (Jan 14)
10.Treatment of Acute Gouty Arthritis (Aug 13)
11.Drugs used in treatment of Rheumatoid Arthritis (Aug 12)
12.Rheumatoid factor (Aug 11)
13.Methotrexate : its role in Rheumatoid Arthritis (Feb 11)
14.Treatment of Gout (Aug 10)
15.Enumerate systemic manifestations of SLE (Aug 10)
16.Polymyositis (Aug 10)
17.Nodal Osteoarthritis (Sept 09)
18.Osteoarthritis (March 09)
19.Ankylosing spondylitis (Sept 08)
20.Rheumatoid Arthritis (March 08)
21.Medical management of Gout (March 08)
 32

CHAPTER 11 : NUTRITIONAL DISORDERS

10 Marks

1.Write the clinical features , diagnosis , complications & management of

Obesity (Jan 16)
2+2+2+4=10

2.Define bone density . How is it measured ? What are the clinical features &
treatment of Osteoporosis ? (Sept 07)
2+3+2+3=10

4 Marks

1.Vitamin-D (Jan 17)

2.Marasmic Kwashiorkor (July 16)
3.Vitamin-D (Feb 13)
4.Hazards of Obesity (Aug 10)
5.Pellagra (Aug 10)

2 Marks

1.Niacin (Vitamin-B3) (July 19)

2.Beri-Beri (Jan 19)
3.Rickets (July 18)
4.Bitot’s spots (Jan 18)
5.Vitamin-C deficiency clinical features (Jan 18)
6.Selenium deficiency (July 17)
7.Causes of Obesity (Jan 17)
8.Mention 4 complications of Obesity (Aug 15)
9.Sources & deficiency manifestations of Vitamin-A (Aug 15)
10.Scurvy (Jan 15)
11.Folic Acid Deficiency (Aug 14)
12.Clinical features of Vitamin-C deficiency (Jan 14)
13.Mention 4 complications of Obesity (Jan 14)
 33

14.Vitamin-Niacin (Aug 13)

15.Vitamin-K (Aug 12)
16.Vitamin-C (Feb 12)
17.Obesity (Aug 11)
18.Vitamin-K (Aug 11)
19.Enumerate functions of Vitamin-B6 (Aug 10)
20.Hazards of Obesity (Sept 09)
21.Selenium (March 09)
22.Vitamin-A (March 09)
23.Obesity (Sept 08)
24.Thiamine deficiency (March 08)
25.Cholecalciferol (Sept 07)
 34

CHAPTER 12 : PSYCHIATRIC DISORDERS

4 Marks

1.Substance Abuse (Jan 20)

2.Tricyclic Antidepressants (July 19)
3.Conversion disorder (July 19)
4.Anxiety Neurosis (July 17)
5.Schizophrenia (Jan 17)
6.Bipolar disorder (July 16)
7.Post Traumatic Stress Disorder (Aug 15)
8.Bipolar disorder (Maniac Depression) (Jan 15)
9.Obsessive Compulsive Neurosis (Jan 14)
10.Anxiety Neurosis (Aug 13)
11.Schizophrenia (Feb 13)
12.Obsessive Compulsive Neurosis (Feb 12)
13.Depression (Feb 11)

2 Marks

1.Atypical Neuroleptics (Jan 20)

2.Give 2 causes of Delirium (July 19)
3.Obsessive Compulsive Disorder (OCD) (Jan 19)
4.Somatization disorders (Jan 19)
5.Tardive Dyskinesia (July 18)
6.Melancholia (July 18)
7.Obsessive Compulsive Neurosis (Jan 18)
8.Atypical Neuroleptics (Jan 18)
9.Post Traumatic Stress Disorder (July 17)
10.Side effects of Antipsychotic drugs (Jan 17)
11.Narcolepsy (Jan 16)
12.Anxiety Neurosis (Jan 16)
13.Schizophrenia (Aug 14)
14.Anxiety Neurosis (Aug 12)
15.Antidepressants (Aug 11)
 35

16.Schizophrenia (Aug 10)

17.Behaviour therapy (March 09)
18.Electroconvulsive therapy (Sept 08)
19.Paranoid schizophrenia (March 08)
20.Lithium (April 07)
21.Delerium tremens (April 07)
 36

CHAPTER 13 : FLUID & ELECTROLYTE DISORDERS

4 Marks

1.Treatment of Hyperkalemia (Jan 19)

2 Marks

1.Treatment of Hyperkalemia (July 17)

2. SIADH (Syndrome of Inappropriate ADH Secretion) (July 17)
3.Urine Spot Sodium Test (Sept 07)
 37

CHAPTER 14 : ONCOLOGY

4 Marks

1.Oncogenes (Jan 19)

2.Oncogenes (Jan 16)

2 Marks

1.Mention 4 oncological emergencies (Jan 18)

2.Acute & late side effects of Radiotherapy (Aug 15)
3.Adverse effects of Chemotherapy (Aug 13)
4.Tumour markers (Aug 12)
5.Radiation hazards (Sept 09)
 38

CHAPTER 15 : GENETIC DISORDERS

10 Marks

1.Describe the features of Autosomal Dominant , Autosomal Recessive , X-

linked & Non-Germ line Inheritances
Write diseases that are transmitted in above pattern (Jan 16)
2+2+2+2+2=10

2.What is Autosomal dominant recessive & Sex Linked Inheritances ? Write

diseases transmitted in above patterns (March 09)
1+1+2+2+2+2=10

4 Marks

1.Genetic Counselling (Jan 17)

2.Frailty syndrome (July 16)
3.Genetic Counselling (Jan 14)
4.Y chromosome linked Inheritance (Sept 07)
5.Polymerase Chain Reaction (April 07)

2 Marks

1.Mention 4 causes of Transient Incontinence of Urine in old age (Jan 18)

2.Antioxidants (July 16)
3.HLA System (Jan 16)
4.Prevention of Falls in elderly (Jan 16)
5.Tumour Suppressor Genes (Jan 15)
6.Define Frailty . Write the difference between Frailty & Disability (Aug 14)
7.Mention 4 causes of Transient Incontinence of Urine in old age (Jan 14)
8.Mention Autosomal Recessive disorders (Feb 12)
9.Antioxidants (Sept 09)
10.Human Leukocyte Antigen (Sept 08)
 39

CHAPTER 16 : DISEASES OF SKIN

4 Marks

1.Bullous eruption of skin (Jan 19)

2.Treatment of Vitiligo (July 18)
3.Scabies (Jan 18)
4.Treatment of Psoriasis (July 17)
5.Acne vulgaris (Jan 16)
6.Lichen planus (Aug 15)
7.Vitiligo (Aug 14)
8.Scabies (Jan 14)
9.Atopic Eczema (Aug 13)
10.Pemphigus (March 09)

2 Marks

1.Factors causing flare-ups of Psoriasis (Jan 17)

2.Allergic contact Eczema (Jan 17)
3.Bowen’s disease (July 16)
4.Molluscum contagiosum (Jan 15)
5.Mention the provoking factors in Erythema Nodosum (Aug 13)
6.Types of Psoriasis (Feb 13)
7.Complications of Scabies (Feb 13)
8.Hypopigmented patch (Aug 12)
9.Scabies (Aug 10)
10.Psoriasis (Sept 09)
11.Scabies (March 08)
 40

CHAPTER 17 : POISONING , VENOMOUS BITES &

ENVIRONMENTAL DISEASES

10 Marks

1.Describe the mode of action , clinical features , diagnosis & management of

Organophosphorus Poisoning (July 19)
10

2.Write the clinical features & management of Barbiturate Poisoning (Jan 19)
5+5=10

3.Write the clinical features & treatment of Lead Poisoning (July 18)
5+5=10

4.Write clinical features & management of Cyanide Poisoning (Aug 14)

5+5=10

5.Write symptoms , signs & principles of management of Organophosphorus

Poisoning (Aug 11)
3+4+3=10

4 Marks

1.Heat Stroke (Jan 19)

2.Management of Organophosphorus Compound Poisoning (Jan 18)
3.General management of Poisoned patient (July 17)
4.Clinical features & management of Arsenic Poisoning (Jan 17)
5.Paracetamol Poisoning (Jan 16)
6.Hyperpyrexia (Aug 14)
7.General management of Poisoned patient (Aug 13)
8.Aluminium Phosphide Poisoning (Aug 12)
9.Chealting Agents (Feb 12)
10.Barbiturate Poisoning (Feb 12)
11.Treatment of Vasculotoxic Snake bite (Feb 11)
 41

12.Lead Poisoning (Aug 10)

13.Management of Barbiturate Poisoning (Sept 09)
14.Management of Snake bite (Sept 09)
15.Management of Organophosphorus Poisoning (Sept 08)
16.Poisonous Snake bite (Sept 08)
17.General principles in management of Poisoning (March 08)’
18.Complications of Copper Sulphate Poisoning (Sept 07)
19.Aluminium Phosphide (Sept 07)
20.Aluminium Phosphide Poisoning (April 07)
21.Anti Snake venom (April 07)

2 Marks

1.Heat Stroke (Jan 20)

2.Treatment of Salicylate overdose (July 19)
3.Aluminium Phosphide Poisoning (July 18)
4.Cholinesterase reactivators (Jan 17)
5.Anti Snake venom (July 16)
6.Chelating Agents (Jan 16)
7.Clinical features of Organophosphorus Poisoning (Aug 15)
8.Clinical features & treatment of Aluminium Phosphide Poisoning (Jan 15)
9.Mention signs & symptoms of Carbon monoxide Poisoning (Jan 14)
10.Drug therapy of Organophosphorus compound Poisoning (Feb 13)
11.Mention 4 Chelating agents & their uses (Feb 13)
12.Treatment of Snake bite (Feb 13)
13.Signs & symptoms of Lead Poisoning (Aug 12)
14.Treatment of Snake bite (Feb 12)
15.Heat Stroke (Aug 11)
16.Paracetamol overdose (Feb 11)
17.Chelating agents (Sept 09)
18.Heat Stroke (Sept 09)
 42

CHAPTER 18 : EMERGENCY MEDICINE & CRITICAL CARE

10 Marks

1.Enumerate salient differences between different types of Respiratory Failure.

Mention in brief the treatment principle (Aug 10)
7+3=10

4 Marks

1.ARDS (Jan 20)

2.ARDS (Acute Respiratory Distress Syndrome) (Feb 13)
3.Mechanical Ventilators (March 09)
4.ARDS (Sept 08)
5.Classify Respiratory Failure . What are the clinical signs of Respiratory Failure
(April 07)

2 Marks

1.Mention & define types of Respiratory Failure (Aug 12)

2.Type-I Respiratory Failure (March 09)
 43

MISCELLANEOUS QUESTIONS

4 Marks

1.Clinical features & management of Anaphylaxis (Jan 17)

2.Clinical features & management of Anaphylaxis (Jan 14)
3.Total Parenteral Nutrition (Sept 08)
4.Tuning Fork Tests (Sept 07)
5.Adult immunization (Sept 07)
6.Azoospermia (April 07)

2 Marks

1.Name 2 Immuno suppressive drugs (Jan 20)

2.Monoclonal Antibodies (Jan 17)
3.Monoclonal Antibodies (Aug 15)
4.Type-I Anaphylactic reaction (Aug 15)
5.Mention 4 cytokines (Aug 13)
6.Mention 4 Immuno suppressive drugs (Feb 13)
7.Mention therapeutic uses of Immunoglobulins (Feb 13)
8.Cytokines (Aug 12)
9.Hypersenitivity reaction (Feb 12)
10.Type-III Hypersensitivity reaction (Aug 10)
11.Interleukins (March 09)
12.Erythrocyte Sedimentation Rate (ESR) (March 09)
13.Type-I Anaphylactic reaction (March 09)
14.Differentiate between kidney swelling spleen & (L) splenic flexure colon
mass (April 07)
15.Principles of Ultrasonography (April 07)
16.Ulcer over Penis (April 07)